Peptide-induced IFN-γ and/or IL-2 clearly increased in both HCs and patients with IBD after first- (day 21) and second-dose vaccination (day 36) in line with the ability of mRNA vaccines to induce spike-specific T cells (13). The gene discussed is IL2; the disease is inflammatory bowel disease.